Viewing Study NCT05879367


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2025-12-25 @ 10:45 PM
Study NCT ID: NCT05879367
Status: RECRUITING
Last Update Posted: 2025-06-25
First Post: 2023-05-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
Sponsor: Orbus Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module